BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38035031)

  • 1. Evolution of pharmacogenomic services and implementation of a multi-state pharmacogenomics clinic across a large rural healthcare system.
    Van Heukelom J; Morgan J; Massmann A; Jacobsen K; Petry NJ; Baye JF; Frear S; Schultz A
    Front Pharmacol; 2023; 14():1274165. PubMed ID: 38035031
    [No Abstract]   [Full Text] [Related]  

  • 2. Implementing comprehensive pharmacogenomics in a community hospital-associated primary care setting.
    Wick JA; Schmidlen T; Grande K; Moretz C; Ashcraft K; Green J; Moyer N; Blaxall BC
    J Am Pharm Assoc (2003); 2023; 63(1):188-192. PubMed ID: 36243653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications for pharmacogenomics in pharmacy practice: A scoping review.
    Hayashi M; Hamdy DA; Mahmoud SH
    Res Social Adm Pharm; 2022 Jul; 18(7):3094-3118. PubMed ID: 34474980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unraveling heterogeneity of the clinical pharmacogenomic guidelines in oncology practice among major regulatory bodies.
    Nagy M; Attya M; Patrinos GP
    Pharmacogenomics; 2020 Nov; 21(17):1247-1264. PubMed ID: 33124490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Description of an Established, Fee-for-Service, Office-Based, Pharmacist-Managed Pharmacogenomics Practice.
    Schuh MJ; Crosby S
    Sr Care Pharm; 2019 Dec; 34(10):660-668. PubMed ID: 31818351
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacogenomics of medications given via nonconventional administration routes: a scoping review.
    Socco S; Wake DT; Lee JC; Dunnenberger HM
    Pharmacogenomics; 2022 Nov; 23(17):933-948. PubMed ID: 36326000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nine-gene pharmacogenomics profile service: The Mayo Clinic experience.
    Matey ET; Ragan AK; Oyen LJ; Vitek CR; Aoudia SL; Ragab AK; Fee-Schroeder KC; Black JL; Moyer AM; Nicholson WT; Shrestha S; McAllister TM; Sinnwell JP; Faubion SS; Lazaridis KN
    Pharmacogenomics J; 2022 Feb; 22(1):69-74. PubMed ID: 34671112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics implementation across multiple clinic settings: a qualitative evaluation.
    Shue SA; Rowe E; Bell LA; Damush T; DeLong A; Gowan T; Skaar T; Haggstrom D
    Pharmacogenomics; 2023 Nov; 24(17):881-893. PubMed ID: 37975236
    [No Abstract]   [Full Text] [Related]  

  • 9. Addressing disparities in pharmacogenomics through rural and underserved workforce education.
    Brown JT; McGonagle E; Seifert R; Speedie M; Jacobson PA
    Front Genet; 2022; 13():1082985. PubMed ID: 36726715
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of a panel-based pharmacogenomics testing program among members of a commercial and Medicare client of a pharmacy benefits manager.
    Steinbach M; Wickizer M; Siwak A; Patel T; Olson J; Horowitz S; Topp R
    J Manag Care Spec Pharm; 2022 Apr; 28(4):485-490. PubMed ID: 35332788
    [No Abstract]   [Full Text] [Related]  

  • 11. Implementation of a pharmacist-provided pharmacogenomics service in an executive health program.
    Liko I; Corbin L; Tobin E; Aquilante CL; Lee YM
    Am J Health Syst Pharm; 2021 Jun; 78(12):1094-1103. PubMed ID: 33772264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience, Knowledge, and Perceptions of Pharmacogenomics among Pharmacists and Nurse Practitioners in Alberta Hospitals.
    Hayashi M; Bousman CA
    Pharmacy (Basel); 2022 Oct; 10(6):. PubMed ID: 36412815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription Patterns and Relationship to Pharmacogenomics Testing in the Military Health System.
    Selig DJ; Livezey JR; Chin GC; DeLuca JP; Guillory Ii WO; Kress AT; Oliver TO; Por ED
    Mil Med; 2021 Dec; 187(Suppl 1):9-17. PubMed ID: 34967405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics implementation in cardiovascular disease in a highly diverse population: initial findings and lessons learned from a pilot study in United Arab Emirates.
    Al-Mahayri ZN; Khasawneh LQ; Alqasrawi MN; Altoum SM; Jamil G; Badawi S; Hamza D; George L; AlZaabi A; Ouda H; Al-Maskari F; AlKaabi J; Patrinos GP; Ali BR
    Hum Genomics; 2022 Sep; 16(1):42. PubMed ID: 36154845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collaborative Counseling Considerations for Pharmacogenomic Tests.
    Zierhut HA; Campbell CA; Mitchell AG; Lemke AA; Mills R; Bishop JR
    Pharmacotherapy; 2017 Sep; 37(9):990-999. PubMed ID: 28672074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of a pharmacist-led pharmacogenomic service in a geriatric clinic: Barriers and outcomes.
    Kehr AM; Ayers G; Saxena S; Hashmi AZ; Erwin AL; Azene A; Hockings JK
    J Am Pharm Assoc (2003); 2023; 63(3):778-784. PubMed ID: 36774236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of Pharmacogenomics in Everyday Clinical Settings.
    Bank PCD; Swen JJ; Guchelaar HJ
    Adv Pharmacol; 2018; 83():219-246. PubMed ID: 29801576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacist Consult Reports to Support Pharmacogenomics Report Interpretation.
    Bright D; Saadeh C; DeVuyst-Miller S; Sohn M; Choker A; Langerveld A
    Pharmgenomics Pers Med; 2020; 13():719-724. PubMed ID: 33328756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of a pharmacist-led pharmacogenomics serviceĀ for the Program of All-Inclusive Care for the Elderly (PHARM-GENOME-PACE).
    Bain KT; Schwartz EJ; Knowlton OV; Knowlton CH; Turgeon J
    J Am Pharm Assoc (2003); 2018; 58(3):281-289.e1. PubMed ID: 29602745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients' perspectives of a pharmacist-provided clinical pharmacogenomics service.
    Martin JL; Lee YM; Corbin LW; Colson R; Aquilante CL
    Pharmacogenomics; 2022 Jun; 23(8):463-474. PubMed ID: 35469451
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.